Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Qianhai Health Holdings Ltd. ( (HK:0911) ) has shared an update.
Qianhai Health Holdings Limited has issued a supplemental announcement to its 2024 annual results and annual report, disclosing additional details on a HK$60.4 million provision for onerous contracts linked to its electronics-related operations. The group booked approximately HK$42.0 million in further provisions on supplier products originally procured in 2022, as market prices remained below purchase costs and overdue penalties, and recognised these as at 30 November 2024 prior to the disposal of the subsidiary that contracted for these purchases. It also recorded a HK$18.4 million provision on electronic component products acquired in 2024 after sharp price declines in a highly volatile market left contract prices above current market levels, though the company stated that these extra disclosures do not otherwise change its reported 2024 results or annual report.
The most recent analyst rating on (HK:0911) stock is a Hold with a HK$0.27 price target. To see the full list of analyst forecasts on Qianhai Health Holdings Ltd. stock, see the HK:0911 Stock Forecast page.
More about Qianhai Health Holdings Ltd.
Qianhai Health Holdings Limited is a Cayman Islands-incorporated company listed in Hong Kong, operating through subsidiaries that include an electronics components trading business. The group procures and sells electronic component products and related supplier-sourced items, exposing it to price volatility in the electronics components market and associated contract risk.
Average Trading Volume: 162,422
Technical Sentiment Signal: Hold
Current Market Cap: HK$49.14M
See more insights into 0911 stock on TipRanks’ Stock Analysis page.